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Traditional medicines are composed of herbal formulations and their active ingredients and constituents 
which play a crucial role in the treatment of various human ailments. Astragalus eremophilus and 
Melilotus indicus (L.) All. (syn. Melilotus parviflora Desf.) are used traditionally as antiperspirant, tonic, 
diuretic, laxative and narcotic agents. The current study was designed to investigate the Astragalus eremo-
philus and Melilotus indicus (L.) All. (syn. Melilotus parviflora Desf.) methanol extracts for their anti-
oxidant, antibacterial and antifungal activities. Fine powder of A. eremophilus and M. parviflora was 
extracted with 70% methanol to get crude methanol extract. Extract was characterized for antioxidant, 
antibacterial and antifungal activities. Antioxidant activity of various concentrations (3 mg/ml, 1.5 mg/
ml, 0.75 mg/ml, and 0.38 mg/ml) of both plant extracts was analyzed using 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) free radical. Salmonella typhemorium, Klebsiella pneumoniae (gram-negative) and Staphylococcus 
aureus, Enterococcus faecalis (gram-positive) bacterial strains were used for assessment of antibacterial 
activities. Antifungal activities of 7.5 mg/ml, 5.0 mg/ml, 2.5 mg/ml (A. eremophilus and M. parviflora) 
were conducted using Aspergillus niger, Aspergillus flavus, Aspergillus fumigatus and Candida albicons. 
At high concentration (3 mg/ml), all the tested fractions of A. eremophilus and M. parviflora methanol 
extracts showed potent antioxidant activities, ranging between 83.8 and 63.33%. Antibacterial activities 
revealed that A. eremophilus showed a maximum zone of inhibition (8.1 ± 0.1) on Salmonella typheno-
rium followed by Enterococcus faecalis (7.2 ± 0.1), Klebsellesa pneumonia (6.1 ± 0.6), and Staphylococcus 
aureus (5.1 ± 0.4), and at highest concentration (7.5 mg/ml), however, maximum zone of inhibition of 
Melilotus parviflora was at 7.5 mg/ml followed by 5.0 mg/ml and 2.5 mg/ml against Klebsiella pneumo-
nia, Staphylococcus aureus, Salmonella typhemorium and Enterococcus faecalis. Antifungal assessment 
of both plant extracts showed that the higher concentration (7.5 mg/ml) has significant inhibitory effect 
as compared to control. The results can lead to the conclusion that A. eremophilus and M. parviflora 
methanol extracts are indeed sources of potential therapeutic compounds against antibacterial, antifungal 
and free radical associated disorders.
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INTRODUCTION
Traditional herbal drugs are composed of herbs, herbal preparations, and finished 
herbal products, that contain active ingredients and bioactive metabolites [1, 2], used 
worldwide for treatment of various human ailments [5, 18]. In a great part of the 
developing countries 70–90% of the population depends on the herbal medications. 
Mostly in Africa 75% of the population relies upon herbal medication for primary 
health care [20, 33]. WHO has assessed that 80% of the world’s population depends 
on herbal remedies for maintaining their good health containing various bioactive 
compounds [3, 37]. Medicinal plants have a powerful origin of both traditional and 
current medications [2]. Currently, pharmaceutical industries have invested a consid-
erable measure of energy and financial sources in evolving natural constituents sepa-
rated from plants [12]. The scientific tests on the antimicrobial activities of herbal 
constituents were first recorded in the late nineteenth century [13, 34]. Commercially 
proven numerous medications used as a part of current medications were first utilized 
in extract form herbal or traditional practices for different purposes that recommend-
ed conceivably valuable biological activity. The essential advantages of utilizing 
medicinal plant remedies are generally more secure than industrial manufactured 
drugs, these latter posing a significant and more inexpensive cure [27]. Plant extracts 
were used for the cure of various diseases and provide a base for every single tradi-
tional system [22, 23]. Chemical constituents of medicinal plants like tannins, flavo-
noids, and phenolic compounds has important therapeutic significance [9, 18], and 
are utilized to cure different ailments [44]. Artemisene separated from Artemisia 
japonica is utilized as antiprotozoal in mammalians, and its alternative item referred 
to as artemitrene for control of malarial infections particularly Pf (Plasmodium falci-
parum) [19]. The spores of Guava herbal are accounted as an extensive number of 
organically dynamic constituents [17]. Different seeds like apricot seeds [46], mango 
kernels [28] and citrus pits [4] have a more noteworthy number of phenolic constitu-
ents. 
The family Annonaceae is a group of blossoming plants which consist of bushes, 
floras or infrequently vines [35]. Bioactive constituents isolated from the family con-
taining herbs revealed energizing natural attributes [14, 29], utilized as anthelmintic, 
bug spray and styptic [2]. Roots of different Astragalus species show are used to 
extremely old and surely well-known medications for the treatment of uterine carci-
noma, leukemia, diabetes, nephritis, and as antiperspirant, tonic, and diuretic [10]. 
Melilotus indicus (L.) All. (syn. Melilotus parviflora Desf.) has been reported to be 
emollient, astringent, strongly laxative and narcotic. It contains coumarin, which is 
reported to be anticoagulant [1]. The present study was therefore undertaken to inves-
tigate the antioxidant, antibacterial and antifungal activities of the crude extracts  of 
both plants.
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MATERIALS AND METHODS
Plant collection and extraction
Plants of Melilotus parviflora and Astragalus eremophilus were collected from the 
nearby agricultural fields of village Kakki, Bannu division K.P.K Pakistan at the peak 
of maturity during April and May 2016. Plants were identified by Assistant Professor 
Dr. Faizan Ullah (Department of Botany, University of Science and Technology 
Bannu), and a voucher specimen (MP-1, AE-1) respectively was submitted in the 
Herbarium of the University for onward reference. After shade drying the plants sam-
ples were cut into small pieces and then ground into fine powder. Seventy g powder 
of each plant was soaked in 300 ml of 70 % methanol at room temperature for 72 hrs. 
Then the extracts were filtered and evaporated using rotary evaporator. 
Antibacterial activity
Agar well diffusion method was used for assessment of antibacterial activities [24, 
39]. Wells were prepared in the nutrient agar media and the plants extracts were intro-
duced in these wells. After incubation, the diameter of the zones of inhibition around 
each well was measured and compared against the zone of inhibition of the known 
concentrations of the standard antibiotics.
Preparation of inoculum
Few colonies of the bacterial isolate were transferred into nutrient broth. Broth was 
then placed in incubator shaker at 37 °C until the visible turbidity was equal or 
greater than 0.5 McFarland standard. It was used within 30 min of preparation.
Stock solution preparation 
7.5 mg of methanol extracts of each plant were solved in 1 ml of dimethyl sulfoxide 
(DMSO) according to standard protocol to obtain 7.5 mg/ml solution, which was 
further diluted into 5.0 mg/ml, and 2.5 mg/m concentrations.
Bacterial strains used
During the assay 2 gram-negative (Salmonella typhemorium, Klebsiella pneumoniae) 
and 2 gram- positive (Staphylococcus aureus, Enterococcus faecalis) bacterial strains 
were used. All the bacterial strains were refreshed in a liquid broth for 12–16 hrs and 
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diluted with saline solution to adjust its turbidity to McFarland 0.5% barium sulfate 
turbidity standard.
Agar well diffusion method
Agar well diffusion method is widely used to evaluate the antimicrobial activity of 
plants. In this method agar plate surface was inoculated by spreading the microbial 
inoculum over the entire agar surface. Holes with a diameter of 6 to 8 mm was 
punched aseptically with a sterile cork borer, where a volume (20–100 µL) of each 
plant extract (7.5 mg/ml, 5.0 mg/ml, and 2.5 mg/ml in DMSO) were introduced into 
each labeled well. Then, agar plates were incubated at 37 °C. Ceftriaxone 1 mg/ml 
was used as positive control. The diameter of the inhibition zone (mm) was measured 
in triplicate. 
Antifungal activity
The agar tube dilution assay was used for the determination of antifungal activities of 
the plants as previously described [11]. Inoculums were prepared using SDA media 
(Saburoud dextrose agar). Methanol extract of each plant was prepared from the stock 
of as 7.5 mg/ml, 5.0 mg/ml, 2.5 mg/ml in DMSO. Terbinafine an antifungal agent 
(1 mg/ml) was used as positive control and pure DMSO as a negative control. 6 ml 
of SDA media was added to each labeled test tube along with 100 µl of prepared plant 
extract. All the test tubes were kept at slant position and allowed to solidify at room 
temperature. Finally, an inoculum of four strains, A. niger, A. flavus, A. fumigatus and 
C. albicons, was added. Tubes with that negative and positive control i.e. pure DMSO 
and terbinafine 1 mg/ml were also inoculated and incubated for a week at 28 °C in 
triplicate. The % of inhibition was calculated as:
Antioxidant activity 
The antioxidant activity was carried out according to a standard protocol [5]. 
2, 2-diphenyl-1-picrylahydrazyl (DPPH) was prepared by solving 3 mg of DPPH in 
50 ml of methanol and was kept at 20 °C till needed. The DPPH stock was further 
diluted with methanol in order to get the correct optical density/absorbance of 
0.980 ± 0.02 at 517 nm on a spectrophotometer (Hitachi,s U-510 Tokyo Japan). A 0.8 
ml (800 µl) of DPPH solution and 0.2 ml (200 µl) of methanolic extracts of each plant 
(3 mg/ml, 1.5 mg/ml, 0.75 mg/ml, and 0.38 mg/ml) were mixed. The tubes were 
placed in dark for 15 min at room temperature. After the absorbance optical density 
% inhibition of fungal growth =
100 linear growth in test sample in mm−
linear growth in control in mm
×100.
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was measured at 517 nm. The % scavenging activity measured sing the subsequent 
formula:
The ascorbic acid was kept as positive control.
RESULTS 
Antibacterial effects of Melilotus parviflora and Astragalus eremophilus
Various concentrations of Melilotus parviflora and Astragalus eremophilus methanol 
extracts were used for the investigation of their antibacterial activity against 4 differ-
ent bacterial strains viz; Klebsiella pneumonia, Salmonella typhemorium, Enterococcus 
faecalis and Staphylococcus aureus using agar well diffusion method. Figure 1 
reveals the effects of Astragalus eremophilus and Melilotus parviflora on Klebsiella 
pneumonia, Salmonella typhemorium, Staphylococcus aureus and Enterococcus fae-
calis. Astragalus eremophilus showed maximum zone of inhibition (8.1 ± 0.1) on 
Salmonella typhenorium followed by Enterococcus faecalis (7.2 ± 0.1), Klebsellesa 
pneumonia (6.1 ± 0.6), and Staphylococcus aureus (5.1 ± 0.4) and at highest concen-
Scavenging % =
control absorbance sample absorbance
control absor
−
bance
×100.
Fig. 1. Antibacterial activity of Astragalus eremophilus
416 Muhammad Nadeem Khan et al.
Acta Biologica Hungarica 69, 2018
tration (7.5 mg/ml) while Melilotus parviflora showed the maximum zone of inhibi-
tion at 7.5 mg/ml followed by 5.0 mg/ml and 2.5 mg/ml against Klebsiella pneumo-
nia, Staphylococcus aureus, Salmonella typhemorium and Enterococcus faecalis 
(Fig. 2). Positive control i.e. Ceftriaxone (1 mg/ml) demonstrated considerable effects 
as compare all the tested plant extract samples and negative control (DMSO).
Antifungal investigation of  Melilotus parviflora and  
Astragalus eremophilus
Fungi causes various human diseases. Antifungal agents obtained from medicinal 
plants play a crucial role in the control of fungal diseases. In the current study the 
antifungal effects of Melilotus parviflora and Astragalus eremophilus against four 
strains of fungi viz; Aspergillus flaveus, Aspergillus niger, Aspergillus fumigatus and 
Candida albicans were tested. Fig. 3 shows that Astragalus eremophilus has maxi-
mum inhibitory potential against Candida albicans (74.2%) followed by Aspergillus 
flavus (63.1%), Aspergillus fumigatus (61.3%) and Aspergillus niger (57.1%) at 7.5 
mg/ml however high concentration of Melilotus parviflora is more potent as compare 
to Astragalus eremophilus. Methanolic extract showed potent activity against 
Fig. 2. Antibacterial activity of Melilotus parviflora
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Candida albicans (77.1%), followed by Aspergillus fumigatus (70.1%), Aspergillus 
flavus (67.5%), and Aspergillus niger (64.0%) respectively (Fig. 4). 
Antioxidant activity of  Melilotus parviflora and Astragalus eremophilus
2,2-Diphenyl-1-Picrylhydrazyl (DPPH) is a free radical and could attract electrons 
from antioxidant. The free radicals scavenging property of the methanol crude extract 
of Astragalus eremophilus, and Melilotus parviflora. The results revealed a direct 
relationship between the concentration of methanol extract and the % scavenging of 
Astragalus eremophilus and Melilotus parviflora. Various concentrations of 3 mg/ml, 
1.5 mg/ml, 0.75 mg/ml and 0.38 mg/ml the free radical scavenging activity of 
Astragalus eremophilus is 83.8%, 72.89, 69.67% and 33.73 ely. The order of % of 
free radicals scavenging activity is 3 mg/ml > 1.5 mg/ml > 0.75 mg/ml and 0.38 mg/
Fig. 4. Antifungal activity of Melilotus parviflora
Fig. 3. Antifungal activity of Astragalus eremophilus
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Fig. 5. Antioxidant activity of Astragalus eremophilus
Fig. 6. Antioxidant activity of Melilotus parviflora
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ml (Fig. 5). Figure 6 shows that various concentrations of methanolic extract of 
Melilotus parviflora (3 mg/ml, 1.5 mg/ml, 0.75 mg/ml and 0.38 mg/ml) has concen-
tration dependent effects (63.33%, 37.75%, 26.97% and 24.96%) against scavenging 
of free radicals respectively. The present study reveals that Astragalus eremophilus 
methanol extract are the most effective as compared to Melilotus parviflora. The 
observed antioxidant activity of the Astragalus eremophilus and Melilitus parviflora 
methanolic extracts might be due to its high phenolic content.
DISCUSSION
Medicinal plants play a significant role in curing various oxidative damages including 
infections, diabetics, inflammation, heart disease, and cancer all over the world. 
Pakistan is rich in natural resources and medicinal floras which has been utilized by 
local communities for treatment of numerous ailments of skin, microbial and diges-
tive disorders [1, 30]. Oxidation is essential process for energy production, however 
during normal metabolism, through a number of enzymatic systems oxygen con-
sumptions produces several reactive oxygen species such as hydrogen peroxide, 
superoxide radical and hydroxyl radical. In small amount these reactive oxygen spe-
cies are useful in growth regulation and signal transduction. However large amount 
of reactive oxygen species produced oxidation stress, attacks protein and lipids mol-
ecules [21]. Data of the present study showed that extracts of both plants has marked 
radical scavenging potential at 3 mg/ml and 0.38 mg/ml concentrations. The antioxi-
dant potential of the plants is due to the presence of bioactive polyphenolic and phe-
nolic compounds which reduce the free radical that cause oxidative stress. The find-
ings obtained by other reports also support our results [16, 25].
Medicinal plant extracts possess significant effects in the treatment of bacterial 
infections. In the current study four bacterial strains were selected to evaluate the 
antibacterial activity of each plant derived fractions. Our results showed that extracts 
obtained from Melilotus parviflora and Astragalus eremophilus display marked inhi-
bitions against all gram positive and gram-negative bacteria. These significant inhibi-
tions against all tested strains may be due to their phytoconstituents such as phenolics, 
tannins, saponins and flavonoids which are recommended for further studies. Several 
studies indicated that antimicrobial manifestations of plant extracts are due to their 
phenolics and contents [6, 31]. Another investigation was reported that catechins 
were more efficient against gram positive bacteria than gram negative bacteria [7, 26]. 
Literature revealed similar finding by other studies [8, 37, 40]. 
Fungal causes various disease in living organism especially in human. To over-
come their toxic effects various types of antifungal products are available in the 
market but all these have some side effects. Therefore, presently scientists are trying 
to develop such type of therapies which are friendly to living cell [39, 40]. As a result 
of their considerations and discoveries they came to an end and prepared natural 
product for their control obtained from various natural sources especially from 
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medicinal plants. In the present project it was demonstrated that Melilotus parviflora 
extracts exhibited maximum antifungal activity. The activity of C. albicans, A. fumig-
atus, A. flavus and A. niger was inhibited by a percentage value of 77.2 ± 1.33%, 
70.1 ± 1.12%, 67.5 ± 1.11% and 64.3 ± 1.37%, respectively. Similar results were 
reported the in the course of characterization of the antimicrobial activity of other 
plants by other scientists [8, 36, 46]. 
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